Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine
- 19 March 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 322 (2-3) , 211-220
- https://doi.org/10.1016/s0014-2999(97)00011-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.Journal of Clinical Investigation, 1994
- Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1993
- Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.Circulation, 1992
- Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.Circulation, 1992
- Functional role of intravascular coronary endothelial adenosine receptorsEuropean Journal of Pharmacology, 1992
- Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine.Circulation Research, 1991
- The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.Journal of Clinical Investigation, 1990
- Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.Journal of Clinical Investigation, 1986
- Effect of Adenosine Deaminase Inhibitors on the Heartʼs Functional and Biochemical Recovery from IschemiaJournal of Cardiovascular Pharmacology, 1983
- Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.The Journal of Experimental Medicine, 1983